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Zivadinov et al ’ JVIR1786 ’ ISNVD Position Statement: Screening Recommendations for CCSVIUnder the auspices of the International Society for Neurovascular Disease (ISNVD), four expert panel committees were created
from the ISNVD membership between 2011 and 2012 to determine and standardize noninvasive and invasive imaging protocols
for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufﬁciency (CCSVI). The
committees created working groups on color Doppler ultrasound (US), magnetic resonance (MR) imaging, catheter venography
(CV), and intravascular US. Each group organized a workshop focused on its assigned imaging modality. Non–ISNVD
members from other societies were invited to contribute to the various workshops. More than 60 neurology, radiology, vascular
surgery, and interventional radiology experts participated in these workshops and contributed to the development of
standardized noninvasive and invasive imaging protocols for the detection of extracranial venous abnormalities indicative of
CCSVI. This ISNVD position statement presents the MR imaging and intravascular US protocols for the ﬁrst time and
describes reﬁned color Doppler US and CV protocols. It also emphasizes the need for the use of for noninvasive and invasive
multimodal imaging to diagnose adequately and monitor extracranial venous abnormalities indicative of CCSVI for open-label
or double-blinded, randomized, controlled studies.
ABBREVIATIONS
CCSVI = chronic cerebrospinal venous insufﬁciency, CNS = central nervous system, CSA = cross-sectional area, CV = catheter
venography, IJV = internal jugular vein, ISNVD = International Society for Neurovascular Disease, MS = multiple sclerosis,
PREMiSe = Prospective Randomized Endovascular Treatment in Multiple Sclerosis, VH = venous hemodynamic, VV = vertebral
veinThe extracranial venous drainage of the cerebrospinal
nervous system is complex, not widely examined, and
only partially understood (1,2). It is often asymmetric
and presents signiﬁcantly more variability than the
extracranial arterial anatomy that supplies the central
nervous system (CNS). Contrary to other venous terri-
tories, relatively little is known about anatomic varia-
tions and the hemodynamics of the internal jugular veins
(IJVs) (2,3), and even less is known about the azygos
vein (4). Currently, disagreement remains about the
physiologic range of hemodynamic measurements in
these veins, including determination of normal or
abnormal function. The walls of the IJVs and azygos
vein are typically very compliant, with lumen diameters
that are variable and inﬂuenced by postural change,
respiration, cardiac function, hydration status, and even
by the pulsation of nearby arteries (5,6). When imaging
the extracranial venous drainage of the CNS, it is difﬁ-
cult to conﬁdently account for all these factors, and this
can inﬂuence the diagnostic value of the assessment,
regardless of the imaging modality used.
Chronic cerebrospinal venous insufﬁciency (CCSVI) is
a condition characterized by impaired venous drainage of
the brain and spinal cord as a result of outﬂow obstruc-
tion in the extracranial venous system caused by stenoses
or obstructions of the IJVs and/or azygos vein. Currently,
its noninvasive diagnosis is based on the color Doppler
ultrasound (US) evaluation of ﬁve venous hemodynamic
(VH) criteria in the extracranial (ie, neck) and intracranial
veins (4). The initial study found that two or more of
the ﬁve proposed criteria were met in a high proportion
of patients with multiple sclerosis (MS) (4). However,
subsequent studies demonstrated that the condition is
not unique to patients with MS and that healthy indi-viduals and patients with other CNS disorders can also
fulﬁll multiple VH criteria (7–13). Conversely, several
recent color Doppler US studies reported extremely low
rates of CCSVI, diagnosed based on two or more positive
color Doppler US criteria, in patients with MS and
healthy individuals (14–20).
Because the reproducibility of the categoric CCSVI
color Doppler US-based diagnosis depends on the train-
ing level and skills of the operator and blinding and
reading criteria (7,8,20–23), the usefulness and applic-
ability of the CCSVI color Doppler US-based diagnosis
in clinical research and practice is limited. Moreover,
because healthy individuals do not have CNS disorders,
its clinical relevance as a nosologic entity was immedi-
ately questioned (24). CCSVI implies a pathologic
condition or disorder characterized by extracranial ven-
ous structural/morphologic, hemodynamic/functional
abnormalities. Whether this condition is primarily
characterized by clinical symptoms, such as headache,
fatigue, sleep disturbances, and autonomic dysfunctions
that can be improved by using endovascular treatment is
unclear at this time (25).
A variety of other noninvasive and invasive imaging
modalities have been proposed for the screening and
diagnosis of CCSVI (5). In addition to color Doppler
US, magnetic resonance (MR) imaging, speciﬁcally MR
venography, has been proposed as a screening exa-
mination for CCSVI (8,16,26–31). MR venography
allows noninvasive visualization of the entire venous
system of the neck, central chest veins, brachiocephalic
veins, and dural sinuses, but it cannot satisfactorily
evaluate the azygos and hemiazygous veins (5).
Catheter venography (CV) is considered the invasive
gold-standard method for visualization of the IJVs and
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conditions because the density of injected contrast media
may obscure intraluminal abnormalities (4,13,31–33).
More recently, intravascular US is emerging as an impor-
tant diagnostic tool for detection of venous abnormalities
indicative of CCSVI (32–37).
In a recent debate article, Zivadinov and Chung (25)
emphasize that one of the central issues regarding
CCSVI to be further investigated is the deﬁnition of a
signiﬁcant narrowing of the extracranial venous system
with hemodynamic consequences for the intracranial
venous drainage. They critically report that the current
deﬁnition (narrowing of 4 50% in respect to the
proximal adjacent vein segment) is mainly derived
from observations in the arterial system and is
therefore probably inadequate for the venous system.
Probably even more important is to establish what
constitutes a signiﬁcant narrowing of the extracranial
venous system with hemodynamic consequences for the
intracranial venous drainage. Therefore, at this time,
there is no established noninvasive or invasive diagnostic
imaging modality that can serve as a gold standard for
the detection of the extracranial venous abnormalities
indicative of CCSVI (14,15,17,20,38). It is possible that a
more appropriate choice of stenosis of hemodynamic
consequence will be rather a ﬁxed value for absolute
cross-sectional area (CSA). Nevertheless, more sophisti-
cated and validated multimodal imaging criteria are
needed to adequately assess the clinical impact of
extracranial venous abnormalities indicative of CCSVI
for CNS pathologic conditions.
The present ISNVD reports for the ﬁrst time recom-
mended standardized noninvasive and invasive imaging
protocols for evaluating extracranial venous abnormal-
ities indicative of CCSVI.METHODS
Under the auspices of ISNVD, four committees were
created from the ISNVD membership between 2011 and
2012 to determine and standardize noninvasive and
invasive imaging protocols for detection of extracranial
venous abnormalities indicative of CCSVI. The four
committees were composed of authorities with exper-
tise in color Doppler US, MR venography, CV and
intravascular US, respectively. The composition of
the committees and their chairmen and relative mem-
bers is described in the Acknowledgments. The selection
criteria for committee members included previously
published peer-reviewed manuscripts in the area of their
expertise.
Each committee created a working group that organ-
ized workshops focused on their assigned imaging
modality. Workshop participants were selected based
on their scientiﬁc background and active use of the
speciﬁc imaging modality. Non-ISNVD members fromother societies, including the International Union of
Phlebology, International Union of Angiology, European
Venous Forum, American College of Phlebology, Aus-
tralian College of Phlebology, Italian Society of Angiol-
ogy and Vascular Pathology, and Italian Society for
Vascular Surgery, were invited to contribute to the
various workshops. More than 60 neurology, radiology,
vascular surgery, and interventional radiology experts
participated in these workshops and contributed to the
development of standardized noninvasive and invasive
imaging protocols for detection of extracranial venous
abnormalities indicative of CCSVI.
The relative workshops were held at the ﬁrst ISNVD
meeting in 2011 in Bologna, Italy; at the second ISNVD
meeting in 2012 in Orlando, Florida; and at the third
ISNVD meeting in 2013 in Krakow, Poland. Each
committee created a preliminary draft that was shared
by email in the 3 months preceding the conference to all
invited and/or nominated members. The chairman and
the scientiﬁc secretariat gathered all revisions and critical
points reported in a second document that was publicly
discussed at each workshop. All revisions to the initial
document and subsequent drafts were discussed and
voted on until a consensus was reached. If no consensus
was reached, the critical points on which consensus was
not reached were excluded from the document or it was
emphasized that the debatable points require more
research. Finally, the chairman and committee members
drew up a third document for further revisions and ﬁnal
approval or comments. During the 3-year process, two
position statements focused on two imaging modalities
were developed and published by ISNVD (22,23,39).
The color Doppler US position statement was published
in two scientiﬁc journals respectively listed in the neuro-
science and in the vascular disease ranking (22,23),
whereas the CV position statement was published in a
vascular disease ranking journal (39).
The present ISNVD document further reﬁnes these
two position statements on color Doppler US and CV
and presents for the ﬁrst time the recommended MR
imaging and intravascular US protocols for evaluating
extracranial venous abnormalities indicative of CCSVI.
The ISNVD is basing their recommendations on cur-
rently available literature. However, in cases in which
there was no available literature, the recommendations




Because color Doppler US is noninvasive and provides
high-resolution images with real-time, dynamic inter-
rogation of structural/morphologic and hemodynamic/
functional venous abnormalities at relatively low cost, it
Zivadinov et al ’ JVIR1788 ’ ISNVD Position Statement: Screening Recommendations for CCSVIwas initially proposed as a method of choice for the
screening of CCSVI (4).
Imaging Technique
High-resolution color Doppler US is a noninvasive
method that has been proposed for determining extrac-
ranial venous abnormalities indicative of CCSVI
by assessing ﬁve VH characteristics (Appendix A,
available online at www.jvir.org). (4) At least two of
ﬁve criteria must be met to diagnose CCSVI by color
Doppler US. The original ﬁve color Doppler US criteria
for CCSVI (4) were revised by the ISNVD in 2011
(22,23), and are currently modiﬁed as follows:1.2.
3.Reﬂux in the IJV and/or vertebral veins (VVs) (4,8–
10,12,15,20,35):
a. Bidirectional ﬂow in one or both IJVs in both
positions (supine and upright) or bidirectional ﬂow
in one position with absence of ﬂow in the other
position;
b. Reversal of ﬂow or bidirectional ﬂow in one or
both VVs in both positions.IJV stenosis (8–10,12,15,35):
a. Reduction of proximal IJV CSA in supine position
to no more than 0.3 cm2, which does not increase
with Valsalva maneuver (performed at the end of
the examination). Reduction of CSA of other parts
of the IJV may be of clinical relevance, but
abnormal cutoff values need further exploration,
except for a complete or nearly complete occlusion
of the vein;
b. Structural abnormalities, ie, intraluminal defects
such as ﬂaps, septa, or malformed valves combined
with hemodynamic changes (ﬂow arrest, reﬂux,
increased blood ﬂow velocity), and immobility of
the valve leaﬂets conﬁrmed by M-mode imaging.Absence of detectable ﬂow in the IJVs and/or VVs
despite numerous deep inspirations and bidirectional
ﬂow detected in the other position on the same side
(8–10,12,15,35).4. CSA of the IJV is greater in the sitting position than
in the supine position or is essentially unchanged
despite a change in position (8–10,12,35,40).5. Bidirectional ﬂow in the intracranial veins and sinuses
(recommended to be used as an additional criterion) (4).
Advantages
Color Doppler US has a signiﬁcant role in the evaluation
of CCSVI after endovascular treatment because it can
show the effects of the treatment on the extracerebral
venous outﬂow and can also recognize associated compli-
cations (eg, residual stenosis, venous thrombosis) (41,42).
Disadvantages
A number of studies showed that the recommended
color Doppler US criteria for the diagnosis of CCSVIare operator-dependent and that their reproducibility
depends on the training level and skill of the operator,
based on published studies (7,8,20–23). In addition to
hemodynamic and morphologic assessment of IJVs and
VVs, color Doppler US can detect extracranial collateral
veins, which are probably a compensatory mechanism
associated with CCSVI (2,8); however, it is not techni-
cally feasible to follow the complete course of collateral
veins, which can be imaged by MR venography or CV
(8,13,27,29–31,34).
Summary
In summary, color Doppler US provides a valuable
diagnostic test, when applied by properly trained oper-
ators, for screening of CCSVI and further monitoring.PROTOCOL FOR MR IMAGING
Rationale
Quantitative imaging of CCSVI with MR imaging
provides an opportunity to study not just qualitative
anatomic abnormalities such as stenosis of a major vein
(8,16,18,26–31,43), but also the ability to quantify blood
ﬂow (Appendix B, available online at www.jvir.org).
(26,28). These two pieces of information may provide
new insights beyond those originally proposed by the
CCSVI color Doppler US criteria (4). Speciﬁcally, recent
MR imaging ﬁndings suggest that a relative reduction of
total IJV ﬂow normalized to the arterial inﬂow as
measured from the carotid and vertebral arteries and
an asymmetric dominance of IJV ﬂow on one side of the
neck may be identiﬁed in patients with MS (26).
Additional MR imaging research protocols that have
been used to study CCSVI include angiographic, diffusion,
iron content, oxygen saturation, perfusion, and cerebro-
spinal ﬂuid estimations (Appendix B). Unfortunately, the
complexity and length of these protocols make them
largely impractical for use in a standard clinical setting.
As a complement to the standard clinical neuroimaging
protocol to assess MS and other neurologic diseases used
by neurologists and neuroradiologists alike, a simple,
rapid set of additional sequences to allow the extra-
cranial vasculature to be assessed for anatomic and ﬂow
abnormalities should be established. These noninvasive
measures provide validation of and are complementary to
the color Doppler US measures.
Imaging Technique
A standard brain and spinal cord MR imaging protocol to
study extracranial venous abnormalities, indicative of
CCSVI is given in Table E1 of Appendix B (available
online at www.jvir.org). This MR protocol is based on the
Consortium of Multiple Sclerosis Centers consensus
guidelines for MR studies in patients with MS (44) and
uses an intravenous contrast agent for the initial
evaluation. Subjects returning for another MR scan may
Volume 25 ’ Number 11 ’ November ’ 2014 1789or may not have a contrast agent used. Based on this
standard clinical imaging protocol, the ISNVD suggests
creation of two modiﬁed CCSVI MR imaging protocols
that will provide a rapid basic assessment of venous
anatomy and ﬂow, in addition to standard evaluation of
the brain and spinal cord. The Tier 1 protocol does not use
a contrast agent, whereas the Tier 2 examination does use a
contrast agent. The proposed scans are two-dimensional
time-of-ﬂight (TOF) MR venography, time-resolved con-
trast-enhanced three-dimensional MR angiography and
venography, phase-contrast ﬂow data at different levels
in the neck, as well as the conventional T2-weighted
imaging, ﬂuid-attenuated inversion recovery and pre- and
postcontrast T1-weighted magnetization-prepared rapid
gradient-echo imaging (8,16,18,26–31,43). Both protocols
are rapid, adding only a few minutes onto the conventional
imaging times. As such, the ISNVD recommends that
these MR imaging protocols are adopted into clinical
settings engaged in the diagnosis and monitoring
of CCSVI.Advantages
A major beneﬁt of the use of MR imaging for assessment
of extracranial venous abnormalities indicative of CCSVI
is that it provides the radiologist and interpreting
physician with an assessment of the brain and spinal-
cord pathologic conditions in the CNS. At the same time,
it provides the interventionalist with a three-dimensional
MR venographic map that completely displays the ana-
tomy of any extracranial venous abnormalities to help
guide management decisions and preprocedure treatment
planning. (5) In general, MR imaging is operator-
independent, and similar protocols can be performed
on most clinically MR imaging systems. The data are
also easily reproduced when performed on the same
equipment from site to site.
Potential markers for extracranial venous abnormal-
ities, indicative of CCSVI, can be identiﬁed from the
collected data. MR imaging can longitudinally track the
progress of the CNS disease over time by monitoring
lesion character and volume, tissue atrophy, iron, dif-
fusion, and perfusion and physiologic changes like blood
ﬂow and cerebrospinal ﬂuid dynamics, and provide a
baseline for future scans.Disadvantages
However, there are practical concerns regarding the
implementation of these protocols. Radiologists and
interpreting physicians must be adequately trained to
interpret the images. As with any imaging protocol, the
reader must understand the technical limitations of the
methodology and must have knowledge of the appro-
priate metrics to be analyzed from the quantitative data
created from the examination.Summary
MR imaging offers an important set of measures for
radiologists, interpreting physicians, and interventional-
ists to aid in the detection and treatment of CCSVI.
Diagnosticians must be facile with the appropriate
protocols and metrics and should be familiar with the
beneﬁts and limitations of each protocol used.PROTOCOL FOR CV
Rationale
Assessment of CV imaging of veins draining the CNS
adheres to the traditional guidelines for angiographic
interpretation used for examinations of arteries and other
veins. The majority of CCSVI pathology is conﬁned to the
intraluminal portion of extracranial veins, which requires
high-resolution color Doppler US or intravascular US
B-mode imaging for the visualization of these anomalies
(4,32,33,35–37). Although CV is considered to be the
gold-standard method for detecting stenosis in blood
vessels associated with altered blood ﬂow, the recent
results from Prospective Randomized Endovascular
Treatment in MS (PREMiSe) study (45) showed that
CV may not be sensitive enough to reveal the exact nature
of narrowed vein segments (32,33). Being a luminogram, a
CV image may yield little or no data regarding the vessel’s
intraluminal structures because of dense opaciﬁcation of
the lumen with contrast medium (39). The diluted contrast
medium may allow a better visualization of endoluminal
structures (eg, valve leaﬂets, webs), whereas nondiluted
contrast medium allows a better opaciﬁcation of epidural
and other collateral vessels, as well as a better estimation
of overall features of the veins (34). CV is sensitive in
depicting the extraluminal structural/morphologic abnor-
malities that include narrowing and annulus (5,25).
It is important to acknowledge that there is incomplete
understanding of the anatomy and physiology of the ﬂow
dynamics of the IJVs and the azygos vein, and, for this
reason, it is difﬁcult to reach a consensus on how to
examine these veins and how to interpret the images
obtained during CV. Committee members emphasized
that CV of the IJVs and azygos vein is actually a
“tarnished” gold standard, because even though CV is
widely accepted as the main diagnostic tool for the
assessment of extracranial venous abnormalities indicative
of CCSVI, signiﬁcant differences exist among cardiovas-
cular centers in terms of venographic technique and
interpretation of this test (4,13,14,30–32,34,46–48). There
are some venographic appearances that the committee
could not agree on, such as whether a diameter narrowing
greater than 50% constitutes an abnormality (4,13).
An expert panel of the ISNVD published a position
statement on the assessment of extracranial veins with
details on the technical aspects of CV of the IJVs and
azygos vein and key issues on the interpretation of the
venographic images (39).
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Regarding detection of the extracranial venous abnormal-
ities indicative of CCSVI, the committee agreed on the
general principles of angiographic procedural techniques
(Appendix C, available online at www.jvir.org), but they
still varied signiﬁcantly in terms of the details of image
interpretation. Because of these disagreements, a standard
and widely accepted venographic protocol for the
diagnosis of CCSVI has not been formally established.
However, the panel experts agreed that further research is
necessary and that a detailed description of the methods
used for venographic evaluation and image interpretation
will need to be speciﬁed in future publications on the topic
(39). The inability to establish a consensus on CV is
underscored by the lack of scientiﬁc evidence supporting a
particular angiographic technique or protocol to guide
interpretation of venographic images.
In patients with venographically evident lesions indi-
cative of CCSVI, coexisting hemodynamically relevant
lesions of the veins that are not draining the CNS
directly (eg, iliac, renal, or ascending lumbar veins)
may be identiﬁed (2,4). The clinical relevance of these
abnormalities in terms of any association with neuro-
logic pathophysiology remains uncertain. In addition,
stenoses of cerebral sinuses and intracranial veins are
other potential coexisting ﬁndings.
Advantages
CV is the gold-standard method for imaging veins. It is a
commonly performed low-risk procedure with a safety
record established over decades of experience (4,13,14,
30–32,34,46,47,49).
Disadvantages
Many veins examined by CV display a less obvious
luminal stenosis or functional abnormality. Currently,
some interventionalists would interpret these ﬁndings as
pathologic (eg, intraluminal structures, such as valve
leaﬂets that may or may not be associated with veno-
graphic signs of compromised outﬂow), whereas others
would regard such ﬁndings as normal (50). More
detailed classiﬁcation of intraluminal and extraluminal
extracranial venous abnormalities and their frequency
is provided in a recently published debate article by
Zivadinov and Chung (25).
Uncertainties related to the use of CV for detection of
extracranial venous abnormalities indicative of CCSVI
can be grouped into several domains: the preferred
vascular access for CV, the ideal dilution of contrast
media used, deﬁnition of reﬂux during contrast agent
injection, interpretive guidelines (including whether
venous diameter and anatomy of accompanying venous
collateral network should be taken into account), time (in
seconds) of delayed emptying of the interrogated vein
(51), the deﬁnition of a pathologic valve and other
abnormal intraluminal structures, whether intravascu-lar US should accompany a routine CV evaluation for
CCSVI, whether a phasic stenosis (ie, a narrowing that is
transient or dynamic) should be regarded as a normal
variant or pathologic, and how to classify venogra-
phically obvious CCSVI lesions (13,32,34–37,39).Summary
Given the lack of a scientiﬁc validation for any given CV
protocol, it has been recommended that any future
publication on extracranial venous abnormalities indi-
cative of CCSVI that deals with angiographic assessment
should include a detailed description of the technique
used and a deﬁnition of pathologic ﬁndings. Most of the
published papers on CCSVI lack these details, which
limits a rigorous analysis of presented data (4,13,14,30–
32,34,46–48,52). It is hoped that a detailed description of
CV in a manner similar to that proposed by the ISNVD
CCSVI CV protocol accompany future publications to
enable a better comparison of study results.PROTOCOL FOR INTRAVASCULAR US
Rationale
Intravascular US is proposed as an additional procedure
that can provide further information regarding extrac-
ranial venous structural abnormalities indicative of
CCSVI (37). Compared with CV, its high image
resolution provides a more detailed view of the lumen.
In addition, intravascular US can provide information
about the azygos vein, as well as intraluminal lesions
such as webs, septum, or immobile valves, which are
frequently difﬁcult to detect by CV (37).
Intravascular US can provide diagnostic details that
may address many of the diagnostic deﬁciencies that
elude detection by color Doppler US, MR venography,
and CV (32–37). Intravascular US is useful in character-
ization of the vessel wall and the endothelium. In addi-
tion, intravascular US presents a real-time cross-sec-
tional view that allows visualizations of possible stenoses
during a variety of physiologic maneuvers such as
Valsalva and reverse Valsalva, inspiration and expira-
tion cervical, ﬂexion and extension, and varying degrees
of neck rotation (53). Neglen and Raju (54) have argued
effectively for the use of intravascular US in chronic iliac
venous stenosis and occlusions. They frequently recogni-
zed an irregular shape of the iliac vein, and, consequ-
ently, the difﬁculties in using diameter determinations
from a single projectional venographic view to make
stenosis measurements. They point out that cross-
sectional morphology may provide prognostic value in
terms of accurately predicting clinical improvement after
balloon angioplasty. Further, they emphasize that intra-
luminal abnormalities, such as immobile valves, subinti-
mal edema, and echogenic material (eg, trabeculae,
septa, and webs) cannot be seen by CV (54).
Volume 25 ’ Number 11 ’ November ’ 2014 1791Imaging Technique
To standardize intravascular US application across
centers, the ISNVD expert committee on intravascular
US proposed a CCSVI intravascular US protocol
(Appendix D, available online at www.jvir.org).
Intravascular US may be indicated in CCSVI for the
detection of intraluminal venous pathologic conditions,
for stenosis analysis, as an aid for assessing dynamic or
atypical narrowings, and as an interventional postan-
gioplasty examination (32–37). In unusual circumstan-
ces, intravascular US enables diagnostic and therapeutic
procedures without the use of iodinated contrast media.
This is particularly relevant in the evaluation and treat-
ment of patients who have had potentially life-
threatening allergic reactions to contrast media or who
have severe renal insufﬁciency.
Advantages
The frequency of intraluminal lesions in patients with
extracranial venous abnormalities indicative of CCSVI
suggests that an intraluminal imaging study is appro-
priate for the complete diagnosis of this pathologic
condition. CV can demonstrate the major stenotic
lesions, but superimposition of valvular cusps and reﬂux
opaciﬁcation of the vessel distal to a stenosis may
obscure the evaluation of valvular narrowing (32–37).
Moreover, CV cannot distinguish the various etiologies
of such stenoses. Abnormal valves characterized by
echogenic irregular thickening, poor mobility, and bulg-
ing cusps, as well as an accompanying septum and/or
webs, are more easily seen by intravascular US because
these features are highly echogenic. Neglen and Raju
(54) have published evidence that such a venous
pathologic state in the iliac vein is unrecognized by
venography and yet it is well seen by intravascular US.
Most recently, Karmon et al (32) described intravascular
US ﬁndings of intraluminal hyperechoic ﬁlling defects
and parallel double-barrel lumens in the veins of patients
with MS. In addition, the results from the PREMiSe
study (45) showed that CV may not be sensitive enough
to reveal the exact nature of narrowed IJV segments
(32,33). Another major advantage of intravascular US is
that a vein can be imaged in a speciﬁc area, having the
patient change the position of the head and determine if
a stenosis is a true stenosis or an effect of a compression
(especially at the level of the thyroid gland) (34).
Finally, intravascular US provides an excellent means
of evaluating the effectiveness of venoplasty and valvu-
loplasty. The opening of immobile valves is particularly
well appreciated by intravascular US. In addition,
complications of angioplasty, such as thrombus and
dissection, are readily identiﬁed with intravascular US.
Disadvantages
There is little published in the medical literature about
the use of intravascular US in the IJV and the azygosvein (32–37). The sensitivity of intravascular US can be
affected by the frequency of the transducer, gain settings,
depth of penetration, and focal depth (5,37).
Summary
Additional research should be focused on improving
resolution of the transducer/detector, developing the
capability to measure ﬂow and pressure, and analyzing
the accuracy of intravascular US.DISCUSSION
The difference in CCSVI prevalence between different
published studies that use noninvasive or invasive
imaging techniques emphasizes the urgent need for
the use of a multimodal imaging approach for better
understanding of the venous abnormalities indicative of
CCSVI (5). Multimodal studies that use noninvasive
and invasive imaging techniques to detect CCSVI are
rapidly emerging (4,8,13,14,16,27,30–36,38,48). The
ﬁndings of these studies are important to better under-
stand the actual prevalence of extracranial venous
abnormalities indicative of CCSVI in patients with
MS, healthy individuals, and patients with other CNS
disorders. Most of the recent invasive studies that used
intravascular US suggest that the frequency of extrac-
ranial venous abnormalities indicative of CCSVI may
be higher than previously reported (32–37). For exam-
ple, in a recent article, Zivadinov et al (33) evaluated the
two noninvasive and two invasive multimodal imaging
correlates of 20 patients with relapsing MS who were
enrolled in the PREMiSe study (45). They concluded
that a noninvasive and invasive multimodal imaging
diagnostic approach should be recommended to depict a
range of extracranial venous abnormalities indica-
tive of CCSVI. In another study, Traboulsee et al (13)
reported that 74% of patients with MS, 70% of healthy
control subjects, and 66% of unaffected siblings
of patients with MS showed greater than 50% narrow-
ing on the CV in at least one of these three extracra-
nial veins. These ﬁndings contradict a number of
recent color Doppler US studies that report an extre-
mely low prevalence of CCSVI in patients with MS
(14,15,17,20,38).
The ISNVD recommends a multimodal noninvasive
and invasive approach to determine what is the true
prevalence of CCSVI in patients with MS and other CNS
disorders, as well as in healthy individuals. The proposed
imaging protocols were created with the contributions of
more than 60 neurology, radiology, vascular surgery, and
interventional radiology experts who participated in the
ISNVD workshops held at the ISNVD Annual Meetings
between 2011 and 2013. The ISNVD understands that
more multimodal validation studies should be performed
before the ﬁrm recommendations about the best combi-
nation of different imaging techniques for diagnosis
Zivadinov et al ’ JVIR1792 ’ ISNVD Position Statement: Screening Recommendations for CCSVIand monitoring of extracranial venous abnormalities
indicative of CCSVI can be proposed. In the meantime,
the ISNVD recommends that at least one noninvasive
and one invasive technique should be performed to detect
extracranial venous abnormalities indicative of CCSVI.
Use of noninvasive multimodal imaging is recommended
for monitoring purposes.CONCLUSIONS
Although some CNS disorders have been linked to the
presence and severity of CCSVI, the ultimate cause–
consequence relationship has not been ﬁrmly established
(25). Therefore, it is not clear at this time which patient
population should undergo the noninvasive and invasive
studies for detection of extracranial venous abnormal-
ities. The ISNVD recommends the use of a multimodal
noninvasive and invasive imaging approach to optimally
identify extracranial venous structural/morphologic and
hemodynamic/functional abnormalities indicative of
CCSVI. Creation of more quantitative imaging criteria
are needed for further characterization of these venous
abnormalities. Screening and monitoring of these venous
abnormalities with the use of a combined noninvasive
and invasive imaging approach should help establish the
actual incidences and prevalence of extracranial venous
abnormalities indicative of CCSVI in various popu-
lations. In addition, a multimodal imaging approach
will address whether these abnormalities can cause
signiﬁcant hemodynamic consequences for intracranial
venous drainage. The proposed noninvasive and invasive
imaging protocols represent a ﬁrst step toward estab-
lishing and validating the criteria for detection and
monitoring of extracranial venous abnormalities indic-
ative of CCSVI in open-label or double-blinded random-
ized controlled studies. The ISNVD recognizes that the
rapidly evolving science and growing interest in this ﬁeld
will facilitate a reﬁnement of these protocols in the near
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For the chronic cerebrospinal venous insufﬁciency
(CCSVI) assessment, a high-end color Doppler ultra-
sound (US) scanning system equipped with two vascu-
lar US transducers is required (55–58). A linear-array
broad-bandwidth probe suitable for superﬁcial vascular
imaging (7.5–13 MHz) is recommended to assess the
extracranial neck veins (internal jugular veins [IJVs]
and vertebral veins [VVs]). A phased-array transducer
with a lower-frequency bandwidth (2–3 MHz) is recom-
mended to investigate the deep cerebral veins and
sinuses.
When visualization of the jugular–subclavian junction
segment proves technically challenging, the use of a
curvilinear/microconvex probe with a smaller footprint
may be useful. The color-ﬂow and spectral Doppler
setting should be adjusted according to the guidelines
and, in turn, optimized on each patient.
Attention should be paid especially to the pulse
repetition frequency (PRF) and wall ﬁlter setting. The
former has to be lowered to detect lower ﬂow rates or
increased to avoid aliasing when the actual velocities
appear higher than predicted, and the latter has to be
set to the detection of low velocity. Whereas the
steering angle and color gain should be regulated to
ensure the complete color ﬁlling of the vessel is under
investigation.
When examining venous ﬂow to include full range of
velocities and all areas of reﬂux or absence of ﬂow, the
sample volume needs to be open completely for the
entire lumen and must be placed in the centre of the
vessel. The angle of insonation of the Doppler beam to
the direction of ﬂow should be 601. However, this may
be difﬁcult to achieve in the IJV and VV without
applying pressure on the skin by changing the angle of
the probe, and reducing the angle down to 451 is
acceptable. It is recommended to never use an angle
greater than 601.
The patient has to be comfortably positioned on an
electromechanical chair or a standard tilt bed. The
examination starts in the supine posture with the head
in the natural position and always looking upward and
forward. The patient should breathe normally through
the nose, and no Valsalva maneuver is required. When
the ﬁrst phase is complete, the examination is repeated
with the patient in the upright (901) position, again
keeping the head facing forward. Two or three minutes
should be allowed for adaptation before starting after
changing from the supine to the upright position. The
patients should be well hydrated to avoid a negative
impact on the ﬁlling of the veins (55–58).
Extracranial Examination
The extracranial examination begins on the right side, in
the transverse plane, and, with the lightest possible
pressure, it locates the jugular vein. A large amount of
ultrasonic gel should be used to avoid excessive pressure
on the patient’s neck that may change the shape and
dimension of the IJV and to ensure complete coupling
between the transducer and the patient’s skin, avoiding
black cones and dark areas on the image.
The IJV is then assessed at three different levels named
J1, J2, and J3 (55,56):
J1 is the most inferior portion of the IJV and portion
closest to the heart. It includes the inferior jugular bulb
and the area of the conﬂuens of the IJV with the
subclavian vein to form the brachiocephalic vein;
J2 is the middle of the vein at the level of the thyroid
gland and includes the oriﬁce of the facial vein; and
J3 is the most superior portion of the IJV beginning
near the angle of the mandible and extending to the skull
base and superior jugular bulb.
B-Mode Evaluation. Starting from the base of the
neck (ie, J1) to the angle of the jaw (ie, J3) a B-mode
evaluation is performed. The search of the abnormalities
should be primarily performed in the supine position
because, in this hemodynamic situation, the jugular veins
are physiologically dilated and it is easier to ﬁnd a lesion
or malformation. After evaluation in the transverse
plane, the IJV has to be completely evaluated in the
longitudinal plane. The most frequent area of an
intraluminal abnormality obstacle is J1 because of the
physiologic presence of the valve at the termination of
the IJV just before its junction with the subclavian vein.
The major abnormalities that can be found at the level of
the IJV valve are a ﬂap, septum, annulus, double
channel, or anomalous orientation of the valve leaﬂets
(eg, inverted position of the leaﬂets, leaﬂets positioned
on the lateral side of the jugular wall). Additionally,
and similarly to cardiac valve evaluation by echo-
cardiography and/or in the deep venous system of the
lower extremity, the M-mode may detect signiﬁcant
information about the mobility of the valve’s cusps
(immobile leaﬂets, immobility limited to one of the two
leaﬂets).
Hemodynamic Evaluation. Hemodynamic evaluation
requires veriﬁcation by longitudinal imaging. Starting
from the lower end of the middle segment of the IJV
(ie, J2), the ﬂow direction should be observed by means of
color mode, asking the patient to breathe quietly through
the nose. Subsequently, the ﬂow direction and duration of
reﬂux/bidirectional ﬂow should be proven by means of a
Doppler spectral analysis. The absence of ﬂow in color
Doppler mode should be conﬁrmed by Doppler spectral
analysis and absence of thrombosis by compression. This
measurement is repeated at the levels of J3 and J1 as well.
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It is suggested to insonate the lower part of the IJV (ie, J1)
last, after careful evaluation of the J2 and J3 segments.
Reﬂux or absence of ﬂow may occur and can be detected
in any segment of the IJV.
Measurements of Cross-Sectional Area. The cross-
sectional area (CSA) measurements are performed in
transverse B-mode scans of the middle segment (ie, J2) by
using the appropriate area measuring tool and has to be
recorded at the same point in supine and sitting positions.
If the CSA in supine position is smaller than in the
upright position, it is considered pathologic.
VV Examination. VVs have to be examined in visible
segments (the easiest segment to be examined is between
C5 and C6) with the transducer positioned longitudi-
nally. When the patient is in the supine position, the
blood ﬂow within the VV is slower, and a lower color
Doppler PRF and wall ﬁlter is needed. It is considered
reﬂux when the vein ﬂow has the same direction of the
arterial one. This reversed ﬂow, which is also considered
as abnormal (ie, reﬂux), may be the result of activation
of collateral vessels connecting extravertebral with
intravertebral veins. Because, in many individuals, the
VVs are tortuous, a “reversed” ﬂow direction can be a
reﬂexion of such a irregularity and not of actual reﬂux.
Insonation of the vein in different locations may be
helpful to resolve such a diagnostic problem.
Intracranial Examination
The cerebral venous system is usually investigated by
means of transcranial access, usually through the tem-
poral window; however, the transoccipital approach has
also been described (59–61).
Both approaches provide satisfactory images and
hemodynamic information, especially of the Rosenthal
vein, and less frequently of the Galen vein and straight
sinus (59–62).
However, it is very rare to ﬁnd ﬂow abnormalities in the
veins through the aforementioned approaches. In fact, the
intracranial veins cannot be modulated like the extracra-
nial one by the activation of the respiratory pump, because
the skull prevents any modulation of atmospheric pres-
sure. In physiology, it has been proven that a standardized
activation of the thoracic pump does not produce any
signiﬁcant changes in ﬂow and velocity at the level of the
parenchymal veins or of the sinuses (62).
For such a reason, an alternative approach through the
condylar window has been validated by means of fusion
imaging technology between magnetic resonance (MR)
imaging and US (63). The US probe should be placed at
the level of the condyloid process of the mandible,
sloping the tail approximately 101 downward, with the
insonation depth adjusted to 11 cm. A slight pressure
right in the area of the patient’s cheekbone is normal.
This level of pressure is necessary to maintain the probe
on the same position when the operator receives the
Doppler signal of the cerebral veins topic of the
examination. The US scanner should be set starting
with a lower PRF value, which ranges from 370 to 500
kHz; deep inspiration should elicit venous ﬂow at the
depth of about 7 cm. This maneuver helps to identify a
cloud composed by color Doppler US signals, sometimes
within a hyperechoic bright-line representing the sinus
wall, visible immediately below the color ﬂow dynamic
image. The PRF value is then increased to avoid
disturbances caused by vibration produced from the close
anatomic relationship of the sphenoid bone with the
airways. Finally, a further assessment is performed by
placing the Doppler pulse waved sample volume into the
imaged color ﬂow to conﬁrm the presence of venous signal.
This approach allows insonation of the veins of the
base of the skull according to the depth of insonation of
the superior petrosal sinus, the inferior petrosal sinus,
and the contralateral inferior and superior petrosal
sinuses. Because insonation of the petrosal sinuses can
be achieved with the Doppler angle close to 901,
detection of reﬂux in the form of bidirectional ﬂow can
be made only with the use of a multiangle Doppler
system, such as the quality Doppler processing (QDP)
technology (64). QDP enables the operator to
understand which is the blood ﬂow direction within the
examined cerebral veins; a proper adjustment of the
PRF is necessary to clearly visualize the direction
without background Doppler noise. This technology is
not available on all US scanning systems. For such
reason, the ISNVD consensus stated that the intracranial
examination must be considered as an additional
criterion in the diagnosis of CCSVI (55,56).
Fulﬁlment of the CCSVI Diagnosis
The subject is assigned venous hemodynamic (VH) score
calculated by counting the number of positive VH
criteria the subject fulﬁlled (Figs E1–E5). A subject is
considered CCSVI-positive if two or more than two VH
criteria are fulﬁlled and CCSVI-negative if fewer than
two VH criteria are fulﬁlled. Subjects who were not
assessed for a VH criterion as a result of technical
difﬁculty or the absence of ideal equipment (ie, QDP
technology) are assumed to have not fulﬁlled that
criterion. At this time, it is unknown whether the
prevalence of CCSVI between patients with multiple
sclerosis (MS) and healthy individuals, as well as
patients with other central nervous system diseases, is
similar to published literature when bidirectional ﬂow in
the intracranial veins and sinuses is excluded as addi-
tional criterion for the diagnosis of CCSVI (65).
Further Considerations
In addition, the color Doppler US committee discussed
future consideration of two additional screening tests. One
is a proprietary technology called QDP (10) designed to
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insonate the veins at the base of the skull. In particular, it
is difﬁcult to visualize the superior petrosal sinus, the
inferior petrosal sinus, and the contralateral inferior and
superior petrosal sinuses. Because insonation of the
petrosal sinuses requires a Doppler angle close to 901,
detection of reﬂux in the form of bidirectional ﬂow can be
made only by using a multiangle Doppler system. The
QDP technology enables the operator to determine the
direction of blood ﬂow within the examined cerebral veins
and make an adjustment of the PRF to clearly visualize
the direction without background Doppler noise.
Although this technology has been recently validated
(63,64), it still has limited availability. Because of this,
the committee determined that the intracranial examina-
tion of bidirectional ﬂow in the intracranial veins and
sinuses by using QDP technology can only be considered
as an additional criterion for diagnosis of CCSVI (55,56).
However, at this time, it is unknown whether the addition
of this technology will inﬂuence the relative prevalence of
CCSVI between patients with MS and healthy individuals
or patients with other central nervous system diseases (65).
The ISNVD committee proposed further study of an
additional screening method based on color Doppler US
quantiﬁcation (62). A recent study used intravenous
contrast media–enhanced US to assess cerebral
circulation times (CCTs) in patients with MS and
healthy individuals, and to determine whether vascular
abnormalities can be detected in MS (66). The results of
this study (66) showed that, in comparison to control
subjects, patients with MS have a signiﬁcantly prolonged
CCT and more frequently retrograde ﬂow in the IJVs,
but the longer CCT in patients with MS was not related
to CCSVI. Contrast-enhanced US was proposed as an
additional diagnostic modality and research tool that
could help identify cerebral venous abnormalities and
increase our knowledge of this condition (66).
APPENDIX B: MR IMAGING CCSVI
PROTOCOL
In addition to the conventional brain and spinal-cord MR
imaging sequences proposed by the Consortium of Multi-
ple Sclerosis Centers consensus guidelines for MR imaging
studies in patients with MS (67), additional specialized
MR imaging sequences are added to study the vasculature
in the neck (Table E1 and Figs E6, E7). On the vascular
side, anatomic and ﬂow information are collected.
The following imaging protocols with contrast medium
(Table E2) or without contrast medium (Table E3) are
shown for a 3-T scanner but can be extended easily to
other ﬁeld strengths such as 1.5 T (Figs E8, E9). The scans
proposed are: two-dimensional (2D) TOF MR venogra-
phy, time-resolved contrast-enhanced three-dimensional
(3D) MR angiography and venography, phase-contrast
ﬂow data at different levels in the neck, as well as the
conventional T2-weighted imaging, ﬂuid-attenuated
inversion recovery (FLAIR), and pre- and postcontrast
T1-weighted imaging or magnetization-prepared rapid
gradient-echo (MPRAGE) imaging of the brain.
Two-dimensional TOF MR venography scans are
used to detect blood ﬂow in arteries and veins (Fig
E8). Using a saturation band, any ﬂow toward the head
(ie, arterial ﬂow) will be saturated and the ﬂow toward
the heart (ie, venous ﬂow) will be highlighted in a
velocity-dependent manner. From this sequence, veins
are well visualized, and it can be determined if they are
patent, occluded, or stenosed. As the data are collected
with high resolution, vessel cross-section can also be
calculated to evaluate the degree of stenosis.
Three-dimensional contrast enhanced MR angiogra-
phy and venography can also be used to evaluate
vascular abnormalities (Fig E8). The scan uses a T1
reducing contrast agent that passes through all vessels
and leads to an increased signal for vessels in T1-
weighted scans. From the data, 3D anatomic assess-
ments can be performed to evaluate vessel patency.
Atresias, aplasias, truncular malformations, valve issues,
and stenoses can be detected.
Two-dimensional phase-contrast MR images are used
to assess ﬂow dynamics in the head and neck veins as well
as arteries (Fig E9). This information is valuable because
it can corroborate and complement the information in the
2D TOF MR venography and 3D contrast-enhanced MR
angiography and venography. It is not uncommon to
visualize the major veins only later to ﬁnd that many of
the veins have compromised blood ﬂow.
For more conventional imaging, T2-weighted imaging is
used to show tissue with long T2 components such as
edema, cerebrospinal ﬂuid (CSF), tumors, and lesion
pathologic processes. Two-dimensional or 3D FLAIR is
used because the images have suppressed CSF signal.
FLAIR shows periventricular lesions well without the
interference from CSF. Lesion quantity and volume can
also be assessed with FLAIR. Eventually, it may be
possible to compare lesion volume with blood ﬂow or
the subject’s physiologic changes over time. T1-weighted
imaging is used at two junctures of the scanning protocol
to image the head: initially before contrast agent injection
and after contrast agent injection. Lesions that enhance
after contrast agent administration are considered as acute.
Scanning Procedure
 Initially, register the patient along with his/her height
and weight. This plays an important role in ﬂow
quantiﬁcation (tiers 1 and 2);
 Activate appropriate (head, neck, and spine) coils for
imaging the region of interest (tiers 1 and 2);
 Make sure to put the pulse trigger on the subject’s
(left/right) index ﬁnger or, for a better ﬂow quantiﬁ-
cation, cardiac gating can be used (tiers 1and 2);
 Initially, start imaging the head by using T2,
MPRAGE, FLAIR, and T1-weighted imaging
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sequences. Make sure to use the head and neck coils
(tiers 1 and 2);
 Next, move the table to center at the neck and acquire
T2, 3D contrast-enhanced MR angiography and veno-
graphy, and ﬂow quantiﬁcation sequences. Make sure
to use the head and neck coils. Inject the contrast agent
at the fourth or ﬁfth measurement of the 3D contrast-
enhanced MR angiography and venography (tier 2);
 The ﬂow quantiﬁcation plane will be set perpendicu-
lar to the IJVs at the C2/C3 and C6/C7 neck levels
with a velocity-encoded gradient echo imaging of 50
cm/s (tier 2);
 Next, move the table center back to the head and
acquire the data by using the post–gadolinium injec-
tion MPRAGE sequence (tier 2).
Reporting the Data
Beyond the standard clinical diagnostic data review by
the neuroradiologist, one must also consider the 2D
TOF and/or the 3D contrast-enhanced MR angio-
graphic data and the ﬂow data. For the former, one
can consider anatomic and vascular abnormalities in
various vessels, including the carotid arteries, vertebral
arteries, jugular veins, external jugular veins, anterior
jugular veins, VVs, deep cervical veins, vertebral plexus,
facial veins, and thyroid veins. The CSAs of these vessels
can be evaluated at C2/C3 and C5/C6 by using the 3D
contrast-enhanced MR angiography and venography or
the 2D TOF MR venography data.
Further considerations include the presence of
stenoses, truncular venous malformations, and malfunc-
tioning valves. Qualitative evaluation of IJV morpho-
logy includes classiﬁcation into ﬁve categories using
an ordinal scale: absent (ﬂow not visible), pinpoint,
ﬂattened, crescentic, and ellipsoidal, considering each
subject’s score to be their highest level of morphologic
abnormality (68–72). The presence and severity of IJV
caliber changes and non-IJV collateral vessels are graded
by using a four-point scale (73,74). Another more
quantitative criterion that has been used in the recent
literature includes the use of a CSA of less than 25 mm2
(ie, one third of the CSA for an average IJV diameter of
1 cm assuming a circular shape) at the lower half of the
IJV body below C2/C3 to call the vein stenotic and a
CSA of less than 12.5 mm2 at the C2/C3 level as stenotic
(75–77).
The ﬂow can also be reported from the C2/C3 and C6/
C7 levels for arteries and veins (75–78). This can include
the percentage of IJV ﬂow compared with the arterial ﬂow
in that region, the ratio of dominant to subdominant IJV
ﬂow, and the presence of no ﬂow, reﬂux, and circulatory
ﬂow. Users should be aware of aliasing and use antialias-
ing software to process the ﬂow data. The ﬂow data can be
presented in terms of integrated ﬂow in milliliters
per second, speed in centimeters per second, positive ﬂow
in milliliters per second (to show ﬂow toward the brain
and better visualize reﬂux or circulatory ﬂow), or negative
ﬂow in milliliters per second, all throughout the cardiac
cycle. Blood ﬂow in the IJVs can be normalized to the
total arterial ﬂow at a given location as follows: at the C6/
C7 level, total arterial ﬂow includes blood through the
common carotid arteries and the vertebral arteries com-
bined, whereas, at the C2/C3 level, total arterial ﬂow
includes blood through the internal carotid arteries and
the vertebral arteries combined. One such software that is
available for use is Signal Processing in Nuclear Magnetic
Resonance, or SPIN (75–77).
APPENDIX C: CATHETER VENOGRAPHY
CCSVI PROTOCOL
Vascular Access
We recommend the right femoral (or saphenous) vein
access for routine assessment and possible consideration
of a venography of the IJV and azygous veins. Left
femoral vein access may be an option if the screening of
additional veins, such as the left iliac vein, is planned.
Angiographic Contrast
Diluted contrast medium allows a clearer visualization
of intraluminal structures, whereas nondiluted contrast
medium enables a better visualization of the collateral
vessels (79). Also, there is no clear consensus on whether
the contrast medium should be hand- or pressure-
injected. Although hand injection mimics physiologic
venous ﬂow, pressure injectors are more accurate, and
their use is more reproducible and makes some ﬂow-
related analyses quantiﬁable. Consequently, there are
proponents of each approach.
Introducer Sheath, Diagnostic Catheter,
and Guide Wires
Use of an 8-F introducer sheath for routine venography is
recommended (79). The veins should be selectively
cannulated by using a 0.035-inch hydrophilic coated guide
wire, and the venograms should be obtained through a 5-F
angled diagnostic catheter. Radiographs should be taken at
different angles (eg, anteroposterior, lateral, and anterior
oblique). In a case of challenging anatomy, other guide
wires and catheters may be advantageous.
What Should Be Interpreted as a
Pathologic Process
The following lesions should be interpreted as patholo-
gic, and will present with all the following criteria:
 Lesion detected in any part of IJV uni- or bilaterally
(also comprises lesions of the brachiocephalic veins);
or
Lesion of the arch of the azygos vein and/or
ascending azygos vein;
or
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Lesion of the hemiazygous or accessory hemiazy-
gous vein if these veins constitute primary outﬂow
route from the spinal cord;
 At least 50% stenosis of the vein, if compared with
diameter of adjacent segment of the vein; also comprises
severe hypoplasia, complete agenesis, and secondary
occlusion of the vein (eg, thrombotic; (Figs E10, E11);
or
Intraluminal structures, such as webs, septa, or
membranes, which are associated with at least one
additional sign of impaired outﬂow:
○ No outﬂow of contrast agent from the vein,
○ Outﬂow of contrast agent slowed down, ie,
retained in examined vein for longer than one
cardiac cycle,
○ Backward ﬂow of injected contrast agent (using
low-pressure and low-volume injection),
○ Outﬂow of injected contrast agent through collat-
erals instead of the main vein.
 Such an abnormality should be demonstrated by
using hand injection of the contrast agent or the use
of a low-pressure automatic injector.
Debatable Venographic Abnormalities
Debatable venographic abnormalities include any of the
following ﬁndings:
 Lesions of the distal part of the azygos vein, hemi-
azygous vein, or their tributaries;
 Lesions of the hemiazygous or accessory hemiazygous
vein if these veins are not dominant;
 Abnormalities of the VVs;
 Lesions revealed by using a high-pressure injector;
 Stenosis less than 50% with no other sign of compro-
mised outﬂow;
 Intraluminal structures not associated with the signs
of compromised outﬂow;
 Stenosis or intraluminal structures associated with
prestenotic dilation of the vein but no other signs of
compromised outﬂow;
 Phasic stenosis, ie, a narrowing that is not visible
permanently but only during a fraction of the cardiac
or respiratory cycle;
 Stenosis visible only by using inﬂation of compliant
angioplastic balloon or on intravascular US, with no
additional venographic signs of compromised
outﬂow.
APPENDIX D: INTRAVASCULAR US CCSVI
PROTOCOL
Intravascular US is generally used in adjunct to catheter
venography (CV). It may, in limited circumstances, be a
“stand-alone” diagnostic and therapeutic tool in the
presence of contraindications to the administration
of contrast media (ie, in patients with estimated glomer-
ular ﬁltration rate o 45–60 mL/min, especially if
complicated by diabetes mellitus or previous life-
threatening allergic reactions to contrast agents).
Intravascular US is indicated in patients with sus-
pected intraluminal venous pathologic conditions. As
CCSVI is frequently associated with valvular malforma-
tions and other intraluminal causes of obstruction, such
as webs, membranes, duplications, and septa, intravas-
cular US is indicated in the diagnostic evaluation of
suspected outﬂow obstructions of the cerebrospinal
venous circulation.
Technical and cognitive expertise with intravascular
US is essential for its proper use. Observation and
learning in a center where intravascular US is used
routinely in venous disease is advisable before indepen-
dently performing such procedures.
Description of Intravascular US Procedure
Before advancing the intravascular US device through
the right atrium, it is strongly advised that a sheath be
placed across the right atrium. The 0.014–0.018-inch
guide wires used to track the intravascular US device are
so thin that they may buckle into the right atrium or
ventricle and cause ventricular and atrial ectopic
rhythms or other tachyarrhythmias.
When both examinations are performed during a
single treatment, intravascular US should follow CV.
CV provides a topographic analysis of the venous
anatomy and pathology as well as estimations of ﬂow.
At the completion of venography, a 0.014-inch wire is
left at the highest level of intravascular US interrogation
and the diagnostic catheter is exchanged for the intra-
vascular US catheter wire at its furthest reach in the vein
of interest. With the active unit, the device is withdrawn
by hand in one smooth motion from the IJV through the
brachiocephalic vein. Use of the motorized withdrawal
unit is discouraged as it is too slow to be practical in
such a long vessel. The device is then advanced back into
the IJV stopping as needed for further interrogation of
areas of interest. If dural sinus abnormalities are sus-
pected, intravascular US can also be used in the sinus as
a separate examination.
In some cases of very large veins, the intravascular US
ﬁeld of interest may be insufﬁcient to visualize the entire
vein, especially when the intravascular US image lies
eccentrically along one wall of the vein. Maneuvers to
center the intravascular US image rely on advancing the
intravascular US catheter away from the wall by placing
the wire into a branch until the wire and intravascular
US catheter are displaced away from the wall. With the
patient changing head position, it can be determined if a
stenosis is a true stenosis or an effect of a compression
(especially at J2 level). Another alternative would be to
switch to a catheter with lower frequency.
The accumulated data are then viewed in axial and
longitudinal views, looking for echogenic intraluminal
abnormalities such as immobile valves, unileaﬂet valves,
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adhesions, thickening, and thrombus. Webs and septa-
tions are sometimes better visualized on the longitudinal
view. CSA measurements are taken at the sites of
potential angioplasty. Cross-sectional calculations by
intravascular US are superior to ﬂuoroscopic estimations
of diameters. Comparisons of normal vein size versus
stenotic areas can also be calculated more accurately.
Because many abnormalities are diagnosed predomi-
nantly by intravascular US and because most complica-
tions of angioplasty are mural and intraluminal in
nature, intravascular US should be repeated in every
vessel (Fig E12). At completion of the treatment of any
vein, intravascular US is removed and CV proceeds into
the next vessel, again followed by intravascular US.
Figure E2. An example of reﬂux: the blood ﬂow at the level of the superior petrosal sinus shows opposite directions between the two
phases of respiration: (a) during inspiration, the ﬂow is directed toward the frontal side, but during expiration (b), the ﬂow has the
opposite direction toward the occipital side. This ﬁnding shows the presence of reversed blood ﬂow within the examined vessel: the
second VH criterion.
Figure E1. Bidirectional ﬂow in the IJV seen in longitudinal view assessed by a Doppler spectral waveform. The duration of the reverse
ﬂow more than 1 second is well apparent in supine (a) or in sitting position (b), fulﬁlling the ﬁrst VH criterion.
Zivadinov et al ’ JVIR1794.e6 ’ ISNVD Position Statement: Screening Recommendations for CCSVI
Figure E3. B-mode evaluation of the IJV at J1 level (longitudinal view): (a) the arrows indicate a septum in the middle of the vessel
lumen. (b) The immobility of such a septum demonstrated in M-mode (arrow), fulﬁlling the third VH criterion.
Figure E4. (a) An example of absence of detectable ﬂow in longitudinal scan of an IJV in supine (left) and sitting (right) postures. The
PRF has to be settled at no more than 1.2 kHz. This ﬁnding is a reﬂection of positive VH criterion 4a. (b) In this case, the absence of
detectable ﬂow (left) is coupled with the presence of bidirectional ﬂow (right), fulﬁlling VH criterion 4b.
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Figure E5. Upper: example of the CSA measurement of the IJV in the supine position (VH criterion 5). Lower: Example of CSA
measurement of the IJV in sitting position. ΔCSA is negative, as it is greater in the sitting than in the supine position.
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Figure E6. Conventional MR scans show the appearance of MS lesions in the brain. (a) Axial T2-weighted imaging and (b) FLAIR show
hyperintense lesions within the white matter. The CSF signal appears bright on T2-weighted imaging (arrow, a), but, on FLAIR imaging,
the CSF signal intensity is greatly reduced, allowing for the clear visualization of periventricular lesions (arrow, b). (c) Precontrast T1-
weighted imaging is another modality in which MS lesions are observed (arrows), and a major beneﬁt of having a T1-reducing contrast
agent allows for (d) postcontrast T1-weighted imaging in which some MS lesions may become enhanced (arrows). This enhancement
indicates that the blood mixed with contrast agent is able to enter the parenchyma, meaning that the blood–brain barrier is disrupted.
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Figure E7. Spine imaging: T2-weighted imaging covering the cervical spinal cord of a healthy control subject (a,b) and a patient with
MS (c,d) with spinal lesions. A sagittal T2-weighted slice (a) shows healthy white matter with uniform signal through the cervical spinal
cord, and a separate axial T2-weighted slice (b) conﬁrms this appearance. In the patient with MS, hyperintense lesions are noticeable
(arrow, c,d) in the sagittal (c) and axial (d) images.
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Figure E8. Vasculature of the head and neck. Arteries and veins can be visualized with and without the use of an exogenous contrast
agent as represented here in coronal projections of two modalities. (a–c) Dynamic contrast-enhanced MR angiography has temporal
resolution capable of imaging arterial (a), early venous (b), and late venous (c) phases. This allows for the clear visualization of the
arterial system, including the common carotid arteries (arrows, a), as well as the venous system, including the IJVs (arrows, b) and late-
enhancing collateral vessels (arrows, c). (d) With a tracking caudal saturation band suppressing signal within the arterial system, 2D
TOF MR venography allows for the visualization of the venous system as a whole, including the IJVs (arrows, d).
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Figure E9. Quantiﬁcation of blood ﬂow: 2D phase-contrast MR imaging is a method that quantiﬁes velocity passing through the
acquisition slice as shown here at a slice positioned perpendicular to the major vessels of the neck between the sixth and seventh
cervical vertebrae. (a) An axial magnitude image shows clear visualization of the vessels with blood ﬂow in the neck, eg, IJVs (arrows,
a). (b,c) Axial-phase images show signal intensity directly proportional to the velocity of ﬂow through the slice. A reversal of ﬂow is
shown in the IJVs when the signal intensity changes from dark (arrows, b), meaning blood ﬂow toward the heart, to bright (arrows, c),
which indicates blood ﬂow toward the brain. (d,e) When a region of interest is deﬁned containing a vessel, the average velocity can be
calculated from the phase image and then multiplied by the area, giving ﬂow volume (d) and rate (e). Typically, approximately 20–30
time points are collected throughout the cardiac cycle, which are then plotted as a function of time. Consider, for, instance the IJVs
(arrows, d,e). From the phase images, a bright signal indicates positive plotted values, and dark signal indicates negative plotted values.
Notice that the IJV ﬂow volume begins to show a positive acceleration in the integrated ﬂow plot, and the ﬂow rate values change from
negative to positive between approximately 400 and 800 ms, indicating reﬂux of both of these jugular veins.
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Figure E10. Stenosis in the upper part of the left IJV (arrow)
with outﬂow of injected contrast agent through collateral net-
work (arrowhead).
Figure E11. Severe stenosis (arrow) of the right IJV at the level
of the jugular valve.
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Figure E12. Images from a 29-year-old man who presented with a recent onset of relapsing-remitting MS. Symptoms included
cognitive difﬁculties, short-term memory lapses, numbness, urinary retention and incontinence, and imbalance. CV and intravascular
US were performed. (a,b) Frontal and lateral dural sinus venography showed that there was reﬂux into the condylar emissary vein and
the occipital emissary vein. (c) Frontal venography of the IJV showed high-grade stenosis that can easily be missed on venography. (d)
Intravascular US reveals a high-grade stenosis (4 80%) of thickened internal jugular valves (outlined by arrows). (e) A 20-mm high-
pressure balloon was inﬂated to 14 atm to open the valvular stenosis (arrows). (f) After angioplasty appears to have opened the
obstruction, (g) intravascular US shows that there is a second immobile valve in the brachiocephalic vein (arrow). Longitudinal view
clariﬁes the degree of stenosis (double arrowhead). (h) An 18-mm high-pressure balloon inﬂated to 16 atm opened this immobile valve
(arrows), and (i) venography shows improved luminal diameter and better ﬂow. (j) Intravascular US of the brachiocephalic vein shows
that the valve is now open.
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Table E1 . Standard Brain and Spinal Cord MR Imaging Protocol for Patients with Multiple Sclerosis According to the Consortium of
Multiple Sclerosis Center Consensus Guidelines for MR Studies (67)
Sequence
Approximate Time Interval
3-T MR Imaging 1.5-T MR Imaging
Three-plane scout of brain (localizer) 0:15 0:10
Axial T2/proton density, head 2:50 4:30
Axial T2 fast FLAIR 2:30 4:30
Axial T1 head 3D before gadolinium 4:00 4:20
Inject gadolinium (no wait time) 0:00 0:00
Axial T1 head 3D after gadolinium 4:00 4:20
Three-plane scout of cervical spine (localizer) 0:20 0:15
Sagittal T2/proton density, cervical spine 2:10 3:50
Sagittal T1 cervical spine after gadolinium 2:40 5:00
Select axial T2 cervical spine through lesions 1:50* 2:20*
Select axial T1 cervical spine after gadolinium through lesions 1:50* 2:40*
Total time 20:45 (24:25*) 26:55 (31:55*)
* ¼ optional, FLAIR ¼ ﬂuid-attenuated inversion recovery.
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Table E2 . Tier 1 Protocol for Studying CCSVI without Contrast Agent Administration on 3-T MR Imaging
Detail Head (Center at Orbital Ridge) Neck (Center at Chin)
Sequence order 1 2/9 3 4 5/10 6 7 8
Sequence type T2/PD T1 MPRAGE 3D FLAIR
T2/PD







Sequence tse tﬂ tse_vﬂ tse tse tse ﬂ_tof ﬂ_fq_retro
Orientation Axial Axial Sagittal Sagittal Sagittal Axial Axial Axial
TR (ms) 3,000 1,750 6,000 3,200 2,140 4,160 29 95.25
TE (ms) 12,105 2.98 397 22,100 10 94 5.02 10
TI (ms) – 900 2200 – 899 – – –
FA (1) 150 9 – 150 160 130 60 20
FOV (mm2) 256  192 256  256 256  256 256  192 256  256 256  256 320  256 256  256
Matrix size 256  256 512  256 256  256 256  256 256  256 256  256 512  256 448  448
Nz/TH (mm) 46/3 192/1 160/1 17/3 17/3 19/3 128/3 1/2.5
Voxel size (mm3) 1  1  3 0.5  1  1 1  1  1 1  1  3 1  1  3 1  1  3 0.6  1.3  3 0.6  0.6  2.5
Average/meas. 1 1 1 2/1 1/1 3/1 1 1
Concatenations 4 1 1 1 2 1 – –
Phase oversmpl (%) 0 0 0 0 100 0 – 0
Dist. factor (%) 0 0 0 0 0 0 25.0 20
Phase enc. dir R44L R44L A44P A44P H44F A44P A44P A44P
iPAT 2/31 2/24 2/24 2/32 2/27 2/32 2/24 2/24
BW (Hz/pixel) 181 180 781 142 230 250 217 192
Flow comp Slice No No Read No Slice Yes No
Phase partial Fourier Off Off Allowed Off Off Off Off Off
Slice partial Fourier Off Off 7/8 Off Off Off Off Off
Flow mode/direction – – – – – – – Single dir./through plane
Venc. (cm/s) – – – – – – – 50
1st signal/mode – – – – – – – Pulse/retro
Special saturation – – – – – – Tracking F –
Presaturation – – – – – – Gap10 mm; TH 40 mm –
Echo spacing (ms) 11.7 7.6 3.32 11.1 9.94 11.8 – –
Turbo factor 7 - 141 5 9 15 – –
Echo trains per slice 16 - 1 20 30 9 – –
Coils Head Head Head/Neck Head/Neck/SP1,2 Head/Neck/SP1,2 Head/Neck/SP1,2 Head/Neck/SP1,2 Head/Neck/SP1,2
Time 03:26 04:03 05:20 02:13 02:14 1:58* 06:57 01:42 (2)
Total time – – – – – – – 27:37 (29:35)*
Recommendations: (i) follow the sequence order, (ii) put a pulse trigger on the patient’s index ﬁnger, and (iii) ﬂow quantiﬁcation will be done perpendicular to the internal jugular
veins at the C2/C3 and C6/C7 neck levels with a venc of 50cm/s. * ¼ optional, A ¼ anterior, BW ¼ bandwidth, C ¼ cervical, CCSVI ¼ chronic cerebrospinal venous insufﬁciency, dist.
factor ¼ fraction of the slice thickness left between slices for 2D imaging methods, FA ¼ ﬂip angle, FLAIR ¼ ﬂuid-attenuated inversion recovery, FOV ¼ ﬁeld of view, iPAT ¼ increase in
speed factor for parallel imaging, L ¼ left, MPRAGE ¼ magnetization-prepared rapid acquisition gradient-echo, Nz/TH ¼ number of slices/slice thickness, phase enc. dir ¼ phase
encoding direction, phase oversmpl ¼ percentage of extra phase encoding lines collected relative to what is required, P ¼ posterior, PD ¼ proton density, R ¼ right, TE ¼ echo time,













































Table E3 . Tier 2 Protocol for Studying CCSVI with Contrast Medium Administration on 3-T MR Imaging
Detail Head (Center at Orbital Ridge) Neck (Center at Chin)




















Sequence tse tﬂ tse_vﬂ tse tse tse twist ﬂ_fq_retro tse
Orientation Axial Axial Sagittal Sagittal Sagittal Axial Coronal Axial Axial
TR (ms) 3,000 1,750 6,000 3,200 2,140 4,160 3.31 95.25 2,000
TE (ms) 12,105 2.98 397 22,100 10 94 1.25 10 9.9
TI (ms) – 900 2,200 – 899 – – – –
FA (1) 150 9 – 150 160 130 18 20 160
FOV (mm2) 256  192 256  256 256  256 256  192 256  256 256  256 340  255 256  256 256  256
Matrix size 256  256 512  256 256  256 256  256 256  256 256  256 384  384 448  448 256  256
Nz/TH (mm) 46/3 192/1 160/1 17/3 17/3 19/3 96/0.9 1/2.5 19/3
Voxel size (mm3) 1  1  3 0.5  1  1 1  1  1 1  1  3 1  1  3 1  1  3 0.9  0.9  0.9 0.6  0.6  2.5 1  1  3
Average/meas. 1 1 1 2/1 1/1 3/1 1/20 1 2/1
Concatenations 4 1 1 1 2 1 – – 3
Phase oversmpl (%) 0 0 0 0 100 0 0 0 0
Dist. factor (%) 0 0 0 0 0 0 – 20 0
Phase enc. dir R44L R44L A44P A44P H44F A44P R44L A44P A44P
iPAT 2/31 2/24 2/24 2/32 2/27 2/32 2/24 2/24 2/32
BW (Hz/pixel) 181 180 781 142 230 250 650 192 230
Flow comp Slice No No Read No Slice - No No
Phase partial Fourier Off Off Allowed Off Off Off 6/8 Off Off
Slice partial Fourier Off Off 7/8 Off Off Off 6/8 Off Off
Flow mode/direction – – – – – – – Single dir./ through plane –
Venc. (cm/s) – – – – – – – 50 –
1st signal/mode – – – – – – – Pulse/retro –
Echo spacing (ms) 11.7 7.6 3.32 11.1 9.94 11.8 – – 9.94
Turbo factor 7 – 141 5 9 15 – – 9
Echo trains per slice 16 – 1 20 30 9 – – 15
Coils Head Head Head/neck Head/neck/SP1,2 Head/neck/SP1,2 Head/neck/SP1,2 Head/neck/SP1,2 Head/neck/SP1,2 Head/neck/SP1,2
Time 03:26 04:03 (2) 05:20 02:13 02:14 (2) 1:58* 02:26 01:42 (2) 3:08*
Total time – – – – – – – – 29:21 (34:27)*
Recommendations: (i) follow the sequence order, (ii) put a pulse trigger on the patient’s index ﬁnger, and (iii) inject remaining dose of contrast medium at the ﬁfth measurement.
* ¼ optional, A ¼ anterior, BW ¼ bandwidth, C ¼ cervical, CCSVI ¼ chronic cerebrospinal venous insufﬁciency, dist. factor ¼ fraction of the slice thickness left between slices for 2D
imaging methods, FA ¼ ﬂip angle, FLAIR ¼ ﬂuid-attenuated inversion recovery, FOV ¼ ﬁeld of view, iPAT ¼ increase in speed factor for parallel imaging, L ¼ left, MPRAGE ¼
magnetization-prepared rapid acquisition gradient-echo, Nz/TH ¼ number of slices/slice thickness, phase enc. dir ¼ phase encoding direction, phase oversmpl ¼ percentage of extra
phase encoding lines collected relative to what is required, P ¼ posterior, PD ¼ proton density, R ¼ right, TE ¼ echo time, tﬂ ¼ turbo ﬂash, 3D ¼ three-dimensional, TI ¼ inversion time,
TR ¼ repetition time, tse ¼ turbo spin-echo, TOF ¼ time of ﬂight, venc. ¼ velocity-encoded gradient echo imaging.
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